| human | Q5 |
| P268 | Bibliothèque nationale de France ID | 166886337 |
| P5361 | BNB person ID | NicolaNicos1950- |
| P9984 | CANTIC ID | 981058520770406706 |
| P11496 | CiNii Research ID | 1140845216767276288 |
| P4228 | Encyclopedia of Australian Science ID | P003793b |
| P227 | GND ID | 172290287 |
| P1960 | Google Scholar author ID | jVUBkl8AAAAJ |
| P269 | IdRef ID | 112805477 |
| P213 | ISNI | 0000000081747982 |
| P409 | Libraries Australia ID | 36453186 |
| P244 | Library of Congress authority ID | n84205226 |
| P6634 | LinkedIn personal profile ID | nick-nicola-09b6a91 |
| P3835 | Mendeley person ID | nicos-nicola |
| P271 | NACSIS-CAT author ID | DA02139679 |
| P8189 | National Library of Israel J9U ID | 987007449428605171 |
| P1006 | Nationale Thesaurus voor Auteursnamen ID | 140327355 |
| P1315 | NLA Trove people ID | 626231 |
| P1015 | NORAF ID | 90811536 |
| P496 | ORCID iD | 0000-0003-1054-7889 |
| P3368 | Prabook ID | 318412 |
| P3829 | Publons author ID | 1749290 |
| P3065 | RERO ID (obsolete) | 02-A003639379 |
| 02-A003639380 | ||
| P1053 | ResearcherID | D-2989-2011 |
| P2038 | ResearchGate profile ID | Nicos-Nicola |
| P1153 | Scopus author ID | 7102817958 |
| P11686 | University of Barcelona authority ID | 981058520770406706 |
| P1580 | University of Barcelona authority ID (former scheme) | a1309371 |
| P214 | VIAF ID | 109502084 |
| P10832 | WorldCat Entities ID | E39PBJvhrYmM93d9Jgxpd79FKd |
| P166 | award received | Gottschalk Medal | Q5588086 |
| Officer of the Order of Australia | Q9684829 | ||
| Fellow of the Australian Academy of Science | Q59260322 | ||
| P69 | educated at | University of Melbourne | Q319078 |
| P108 | employer | WEHI | Q7966487 |
| P101 | field of work | immunology | Q101929 |
| cytokine | Q212354 | ||
| P106 | occupation | biochemist | Q2919046 |
| P21 | sex or gender | male | Q6581097 |
| Q37018307 | A (selective) history of Australian involvement in cytokine biology |
| Q30858190 | A fusion protein system for the recombinant production of short disulfide-containing peptides. |
| Q33372611 | A mutation in the translation initiation codon of Gata-1 disrupts megakaryocyte maturation and causes thrombocytopenia |
| Q41646869 | Affinity conversion of receptors for colony stimulating factors: properties of solubilized receptors |
| Q30823978 | Affinity maturation of leukemia inhibitory factor and conversion to potent antagonists of signaling. |
| Q28586837 | Agm1/Pgm3-mediated sugar nucleotide synthesis is essential for hematopoiesis and development |
| Q27646869 | An unusual cytokine:Ig-domain interaction revealed in the crystal structure of leukemia inhibitory factor (LIF) in complex with the LIF receptor |
| Q24322983 | Ankyrin repeat and suppressors of cytokine signaling box protein asb-9 targets creatine kinase B for degradation |
| Q45234484 | Anomalous megakaryocytopoiesis in mice with mutations in the c-Myb gene |
| Q48228139 | Behavioural and anatomical effects of systemically administered leukemia inhibitory factor in the SOD1(G93A G1H) mouse model of familial amyotrophic lateral sclerosis |
| Q44482541 | Binding, internalization, and degradation of 125I-multipotential colony-stimulating factor (interleukin-3) by FDCP-1 cells |
| Q44123776 | Biological evidence that SOCS-2 can act either as an enhancer or suppressor of growth hormone signaling |
| Q35953472 | Blocking Endogenous Leukemia Inhibitory Factor During Placental Development in Mice Leads to Abnormal Placentation and Pregnancy Loss |
| Q36288587 | Blocking LIF action in the uterus by using a PEGylated antagonist prevents implantation: a nonhormonal contraceptive strategy. |
| Q62819555 | Cellular Processing of Murine Colony-Stimulating Factor (Multi-CSF, GM-CSF, G-CSF) Receptors by Normal Hemopoietic Cells and Cell Lines |
| Q62819533 | Clearance and fate of leukemia-inhibitory factor (LIF) after injection into mice |
| Q33633115 | Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor |
| Q42565622 | Correction for Zhang et al., The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation |
| Q27679898 | Crystal structure of the TRIM25 B30.2 (PRYSPRY) domain: a key component of antiviral signalling |
| Q33967437 | Crystal structure of the entire ectodomain of gp130: insights into the molecular assembly of the tall cytokine receptor complexes |
| Q36343007 | DEC-205 is a cell surface receptor for CpG oligonucleotides |
| Q34151625 | Deficiency of 5-hydroxyisourate hydrolase causes hepatomegaly and hepatocellular carcinoma in mice |
| Q36219805 | Deletion of the SOCS box of suppressor of cytokine signaling 3 (SOCS3) in embryonic stem cells reveals SOCS box-dependent regulation of JAK but not STAT phosphorylation |
| Q37593683 | Development of hydrocephalus in mice lacking SOCS7. |
| Q52298375 | Differential expression of lectin receptors during hemopoietic differentiation: enrichment for granulocyte-macrophage progenitor cells. |
| Q41640389 | Differentiation commitment in normal hemopoiesis and leukemic transformation |
| Q28245196 | Distinct roles for leukemia inhibitory factor receptor alpha-chain and gp130 in cell type-specific signal transduction |
| Q62818206 | Donald Metcalf (1929–2014) |
| Q36458177 | Dynamics of the SPRY domain-containing SOCS box protein 2: flexibility of key functional loops |
| Q36346668 | Enhancement of human blood eosinophil cytotoxicity by semi-purified eosinophil colony-stimulating factor(s) |
| Q91095526 | Enzymatic Characterization of Wild-Type and Mutant Janus Kinase 1 |
| Q62819858 | Expression of BCR – ABL in M1 myeloid leukemia cells induces differentiation without arresting proliferation |
| Q24550851 | Functional analysis of Asb-1 using genetic modification in mice |
| Q33412741 | Functional characterization of c-Mpl ectodomain mutations that underlie congenital amegakaryocytic thrombocytopenia |
| Q62819918 | Growth Factor-Induced Phosphorylation of c-rasp21 in Normal Hemopoietic Progenitor Cells |
| Q28201918 | Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b) |
| Q42449457 | Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling |
| Q62819873 | Hemopoietic growth factor receptor abnormalities in leukemia |
| Q34933837 | Histidine-367 of the human common beta chain of the receptor is critical for high-affinity binding of human granulocyte-macrophage colony-stimulating factor. |
| Q35137626 | IL-6 promotes acute and chronic inflammatory disease in the absence of SOCS3. |
| Q58039498 | Identification and Characterization of Two Distinct Truncated Forms of gp130 and a Soluble Form of Leukemia Inhibitory Factor Receptor α-Chain in Normal Human Urine and Plasma |
| Q33453217 | Immuno-haematology and blood bank inventory and issue management |
| Q37676036 | Inhibition of IL-6 family cytokines by SOCS3. |
| Q36837473 | Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. |
| Q61989076 | Letter to the Editor: Backbone 1H, 13C and 15N assignments of the 25 kDa SPRY domain-containing SOCS box protein 2 (SSB-2) |
| Q62819864 | Leukemia Inhibitory Factor Is an Autocrine Survival Factor for Schwann Cells |
| Q38317255 | Ligand-specific utilization of the extracellular membrane-proximal region of the gp130-related signalling receptors. |
| Q36735213 | Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. |
| Q35001025 | Localization of the human GM-CSF receptor gene to the X-Y pseudoautosomal region. |
| Q44257096 | Macrophage cell lines transformed by the malignant histiocytosis sarcoma virus: increase of CSF receptors suggests a model for transformation |
| Q62818261 | Mechanism of crosstalk inhibition of IL-6 signaling in response to LPS and TNFα |
| Q33857008 | Mechanistic insights into activation and SOCS3-mediated inhibition of myeloproliferative neoplasm-associated JAK2 mutants from biochemical and structural analyses |
| Q48389907 | Molecular cloning of cDNA encoding a murine haematopoietic growth regulator, granulocyte-macrophage colony stimulating factor |
| Q54645847 | NMR studies of a murine-human chimera of leukaemia inhibitory factor (LIF). Comparison with human LIF. |
| Q41816627 | Negative regulation of gp130 signalling mediated through tyrosine-757 is not dependent on the recruitment of SHP2. |
| Q24642117 | Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice |
| Q28593767 | Point mutation in the gene encoding p300 suppresses thrombocytopenia in Mpl-/- mice |
| Q33894724 | Polycystic kidneys and chronic inflammatory lesions are the delayed consequences of loss of the suppressor of cytokine signaling-1 (SOCS-1). |
| Q47958279 | Polyethylene glycated leukemia inhibitory factor antagonist inhibits human blastocyst implantation and triggers apoptosis by down-regulating embryonic AKT. |
| Q27683911 | Production of a human neutralizing monoclonal antibody and its crystal structure in complex with ectodomain 3 of the interleukin-13 receptor α1 |
| Q37696894 | Purification of a ligand for the EPH-like receptor HEK using a biosensor-based affinity detection approach |
| Q33857419 | Reconstruction of an active SOCS3-based E3 ubiquitin ligase complex in vitro: identification of the active components and JAK2 and gp130 as substrates |
| Q37172111 | Regulation of Janus kinases by SOCS proteins |
| Q36141189 | Regulation of multiple cytokine signalling pathways by SOCS3 is independent of SOCS2. |
| Q31096727 | SH2 domains from suppressor of cytokine signaling-3 and protein tyrosine phosphatase SHP-2 have similar binding specificities |
| Q24537559 | SOCS-6 binds to insulin receptor substrate 4, and mice lacking the SOCS-6 gene exhibit mild growth retardation |
| Q52174469 | SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. |
| Q27676669 | SOCS3 binds specific receptor–JAK complexes to control cytokine signaling by direct kinase inhibition |
| Q51027830 | SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis. |
| Q38354512 | SOCS3 negatively regulates IL-6 signaling in vivo |
| Q36731660 | SOCS5 is expressed in primary B and T lymphoid cells but is dispensable for lymphocyte production and function |
| Q62819899 | Specific binding of leukemia inhibitory factor to murine myoblasts in culture |
| Q40374586 | Structural aspects of cytokine/receptor interactions |
| Q38058751 | Structure and function of the SPRY/B30.2 domain proteins involved in innate immunity |
| Q52176576 | Suckling defect in mice lacking the soluble haemopoietin receptor NR6. |
| Q35822851 | Suppression of cytokine signaling by SOCS3: characterization of the mode of inhibition and the basis of its specificity |
| Q31130829 | Suppressor of Cytokine Signaling (SOCS) 5 utilises distinct domains for regulation of JAK1 and interaction with the adaptor protein Shc-1. |
| Q62819428 | Suppressor of Cytokine Signaling-1 Attenuates the Duration of Interferon γ Signal Transductionin Vitroandin Vivo |
| Q62819390 | Suppressor of Cytokine Signaling-1 Regulates Signaling in Response to Interleukin-2 and Other γc-dependent Cytokines in Peripheral T Cells |
| Q28585800 | Suppressor of cytokine signaling (SOCS)-5 is a potential negative regulator of epidermal growth factor signaling |
| Q53543101 | Suppressor of cytokine signaling 3 regulates CD8 T-cell proliferation by inhibition of interleukins 6 and 27. |
| Q35165316 | Suppressor of cytokine signaling 4 (SOCS4) protects against severe cytokine storm and enhances viral clearance during influenza infection |
| Q35777741 | Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130 |
| Q33695715 | Suppressor screen in Mpl-/- mice: c-Myb mutation causes supraphysiological production of platelets in the absence of thrombopoietin signaling |
| Q58039546 | The Disulfide Bond Arrangement of Leukemia Inhibitory Factor: Homology to Oncostatin M and Structural Implications |
| Q27651007 | The SOCS Box Domain of SOCS3: Structure and Interaction with the ElonginBC-Cullin5 Ubiquitin Ligase |
| Q37289267 | The SOCS box encodes a hierarchy of affinities for Cullin5: implications for ubiquitin ligase formation and cytokine signalling suppression |
| Q35989418 | The SOCS box of suppressor of cytokine signaling-3 contributes to the control of G-CSF responsiveness in vivo |
| Q28205975 | The SOCS box: a tale of destruction and degradation |
| Q40337569 | The SPRY domain of SSB-2 adopts a novel fold that presents conserved Par-4-binding residues |
| Q62819890 | The Unusual Species Cross-reactivity of the Leukemia Inhibitory Factor Receptor α-Chain Is Determined Primarily by the Immunoglobulin-like Domain |
| Q62819883 | The biological consequences of excess GM-CSF levels in transgenic mice also lacking high-affinity receptors for GM-CSF |
| Q27003933 | The biology and mechanism of action of suppressor of cytokine signaling 3 |
| Q40988652 | The box-1 region of the leukemia inhibitory factor receptor alpha-chain cytoplasmic domain is sufficient for hemopoietic cell proliferation and differentiation. |
| Q46941042 | The comparative roles of suppressor of cytokine signaling-1 and -3 in the inhibition and desensitization of cytokine signaling |
| Q27678371 | The dendritic cell receptor Clec9A binds damaged cells via exposed actin filaments |
| Q38334177 | The immunoglobulin-like module of gp130 is required for signaling by interleukin-6, but not by leukemia inhibitory factor |
| Q27685465 | The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism |
| Q39090468 | The role of leukemia inhibitory factor in tubal ectopic pregnancy. |
| Q40289129 | The structure of SOCS3 reveals the basis of the extended SH2 domain function and identifies an unstructured insertion that regulates stability. |
| Q34057877 | The suppressors of cytokine signaling (SOCS) proteins: important feedback inhibitors of cytokine action. |
| Q24671596 | Thrombocytopenia and kidney disease in mice with a mutation in the C1galt1 gene |
| Q37977396 | Towards a four-dimensional view of neutrophils |
| Q24317684 | Twenty proteins containing a C-terminal SOCS box form five structural classes |
| Q36313330 | Two forms of murine epidermal growth factor: rapid separation by using reverse-phase HPLC |
| Q33911059 | Vaginally administered PEGylated LIF antagonist blocked embryo implantation and eliminated non-target effects on bone in mice |
Search more.